These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents. Wang S, Wang X, Liu M, Bai O. Ann Hematol; 2018 Apr; 97(4):563-572. PubMed ID: 29455234 [Abstract] [Full Text] [Related]
7. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm. Zhang X, Sun J, Yang M, Wang L, Jin J. Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682 [Abstract] [Full Text] [Related]
8. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Shumilov E, Mazzeo P, Ghandili S, Künstner A, Weidemann S, Banz Y, Ströbel P, Pollak M, Kolloch L, Beltraminelli H, Kerkhoff A, Mikesch JH, Schliemann C, Haase D, Wulf G, Legros M, Lenz G, Feldmeyer L, Pabst T, Witte H, Gebauer N, Bacher U. Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088 [Abstract] [Full Text] [Related]
20. Clinicopathological analysis of 46 cases with CD4+ and/or CD56+ immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms. Suzuki Y, Kato S, Kohno K, Satou A, Eladl AE, Asano N, Kono M, Kato Y, Taniwaki M, Akiyama M, Nakamura S. Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410 [Abstract] [Full Text] [Related] Page: [Next] [New Search]